Hanson & Doremus Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-32
| Closed | -$3K | – | 526 |
|
|
2025
Q2 | $3K | Buy |
+32
| New | +$3.09K | ﹤0.01% | 458 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$1K | – | 530 |
|
|
2023
Q4 | $1K | Sell |
5
-85
| -94% | -$9.48K | ﹤0.01% | 464 |
|
|
2023
Q3 | $10K | Hold |
90
| – | – | ﹤0.01% | 387 |
|
|
2023
Q2 | $13K | Buy |
+90
| New | +$12.2K | ﹤0.01% | 395 |
|
|
2023
Q1 | – | Sell |
-33
| Closed | -$4K | – | 519 |
|
|
2022
Q4 | $4K | Sell |
33
-120
| -78% | -$13.9K | ﹤0.01% | 490 |
|
|
2022
Q3 | $16K | Hold |
153
| – | – | ﹤0.01% | 397 |
|
|
2022
Q2 | $16K | Hold |
153
| – | – | ﹤0.01% | 407 |
|
|
2022
Q1 | $20K | Sell |
153
-5
| -3% | -$603 | ﹤0.01% | 402 |
|
|
2021
Q4 | $19K | Hold |
158
| – | – | ﹤0.01% | 383 |
|
|
2021
Q3 | $22K | Hold |
158
| – | – | 0.01% | 357 |
|
|
2021
Q2 | $21K | Hold |
158
| – | – | 0.01% | 315 |
|
|
2021
Q1 | $24K | Hold |
158
| – | – | 0.01% | 360 |
|
|
2020
Q4 | $24K | Hold |
158
| – | – | 0.01% | 338 |
|
|
2020
Q3 | $21K | Hold |
158
| – | – | 0.01% | 315 |
|
|
2020
Q2 | $18K | Hold |
158
| – | – | 0.01% | 344 |
|
|
2020
Q1 | $15K | Hold |
158
| – | – | 0.01% | 366 |
|
|
2019
Q4 | $23K | Hold |
158
| – | – | 0.01% | 359 |
|
|
2019
Q3 | $21K | Hold |
158
| – | – | 0.01% | 353 |
|
|
2019
Q2 | $18K | Sell |
158
-121
| -43% | -$14.2K | 0.01% | 382 |
|
|
2019
Q1 | $35K | Hold |
279
| – | – | 0.01% | 300 |
|
|
2018
Q4 | $28K | Hold |
279
| – | – | 0.01% | 309 |
|
|
2018
Q3 | $36K | Hold |
279
| – | – | 0.01% | 311 |
|
|
2018
Q2 | $30K | Hold |
279
| – | – | 0.01% | 346 |
|
|
2018
Q1 | $30K | Hold |
279
| – | – | 0.01% | 359 |
|
|
2017
Q4 | $33K | Hold |
279
| – | – | 0.01% | 343 |
|
|
2017
Q3 | $32K | Hold |
279
| – | – | 0.01% | 327 |
|
|
2017
Q2 | $35K | Hold |
279
| – | – | 0.01% | 312 |
|
|
2017
Q1 | $33K | Hold |
279
| – | – | 0.01% | 305 |
|
|
2016
Q4 | $28K | Sell |
279
-120
| -30% | -$12.9K | 0.01% | 306 |
|
|
2016
Q3 | $50K | Hold |
399
| – | – | 0.02% | 246 |
|
|
2016
Q2 | $47K | Hold |
399
| – | – | 0.02% | 252 |
|
|
2016
Q1 | $41K | Hold |
399
| – | – | 0.02% | 272 |
|
|
2015
Q4 | $40K | Hold |
399
| – | – | 0.02% | 280 |
|
|
2015
Q3 | $36K | Hold |
399
| – | – | 0.02% | 276 |
|
|
2015
Q2 | $42K | Hold |
399
| – | – | 0.02% | 273 |
|
|
2015
Q1 | $45K | Hold |
399
| – | – | 0.02% | 264 |
|
|
2014
Q4 | $44K | Hold |
399
| – | – | 0.02% | 268 |
|
|
2014
Q3 | $39K | Hold |
399
| – | – | 0.02% | 273 |
|
|
2014
Q2 | $40K | Hold |
399
| – | – | 0.02% | 274 |
|
|
2014
Q1 | $37K | Sell |
399
-498
| -56% | -$45.9K | 0.02% | 275 |
|
|
2013
Q4 | $81K | Buy |
897
+123
| +16% | +$10.6K | 0.04% | 214 |
|
|
2013
Q3 | $62K | Buy |
774
+34
| +5% | +$2.68K | 0.03% | 231 |
|
|
2013
Q2 | $54K | Buy |
+740
| New | +$55.3K | 0.03% | 236 |
|
Other funds holding ZBH
Hanson & Doremus Investment Management's ZBH Position: Q3 2025 in Review
Hanson & Doremus Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 32 shares — an estimated $3K sold.
Hanson & Doremus Investment Management first reported a position in ZBH in Q2 2013 and held it in 43 quarters. The position peaked at $81K in Q4 2013. 967 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Hanson & Doremus Investment Management reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Hanson & Doremus Investment Management sold 32 Zimmer Biomet shares in Q3 2025, an estimated $3K.
- Hanson & Doremus Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 43 quarters.
- Hanson & Doremus Investment Management's Zimmer Biomet position peaked at $81K in Q4 2013.
- 967 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Hanson & Doremus Investment Management's 13F filing for Q3 2025, filed 15 Oct 2025.